SCHEMBL18151616

SCHEMBL18151616

CS(=O)(=O)CCn1ccc(Br)cc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20786954 0.79 PSMB1 (0.41) —
SCHEMBL18186968 0.79 ACACB (0.39) —
SCHEMBL1039192 0.76 ACACB (0.41) —
SCHEMBL3670650 0.75 L3MBTL1 (0.36) —
SCHEMBL2536759 0.75 BACE1 (0.31) —
SCHEMBL3675541 0.75 KMT2A (0.39) —
SCHEMBL3658413 0.75 HTR2C (0.44) —
SCHEMBL29079055 0.75 ACACB (0.42) —
SCHEMBL16553415 0.75 — —
SCHEMBL1038331 0.75 PSMB5 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266532-B2 Tricyclic modulators of TNF signaling ABBVIE INC. (US) 2019-04-23 — — US disclosed
US-20180179198-A1 TRICYCLIC MODULATORS OF TNF SIGNALING ABBVIE INC. 2018-06-28 — — US disclosed
US-9856253-B2 Tricyclic modulators of TNF signaling ABBVIE, INC. (US) 2018-01-02 — — US disclosed
US-20160304517-A1 TRICYCLIC MODULATORS OF TNF SIGNALING ABBVIE INC. 2016-10-20 — — US disclosed
Send feedback